Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHA:603168)

China flag China · Delayed Price · Currency is CNY
6.74
0.00 (0.00%)
Apr 30, 2026, 3:00 PM CST
4.01%
Market Cap 2.52B
Revenue (ttm) 462.78M
Net Income (ttm) -238.72M
Shares Out 374.13M
EPS (ttm) -0.64
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,458,600
Average Volume 8,613,666
Open 6.68
Previous Close 6.74
Day's Range 6.61 - 6.80
52-Week Range 6.24 - 9.09
Beta 0.41
RSI 49.38
Earnings Date Apr 15, 2026

About SHA:603168

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 2000 and is based in Pinghu, China. [Read more]

Sector Healthcare
Founded 2000
Employees 1,328
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603168
Full Company Profile

Financial Performance

In 2025, SHA:603168's revenue was 462.78 million, a decrease of -4.38% compared to the previous year's 483.96 million. Losses were -238.72 million, 93.4% more than in 2024.

Financial Statements

News

There is no news available yet.